RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q1 2020
Top Holdings65 positions
ROCKET PHARMACEUTICALS INC | 16.8M | $234.5M | 10.1% | $17.53 | -18.49% | 5 qtrssince 2019-Q1 | Unchanged 0 |
ALNYLAM PHARMACEUTICALS INC | 1.7M | $183M | 7.9% | $81.24 | +33.96% | 5 qtrssince 2019-Q1 | Increased 61 |
PTC THERAPEUTICS INC | 3.9M | $175.4M | 7.6% | $38.99 | +9.10% | 5 qtrssince 2019-Q1 | Increased 61 |
DICERNA PHARMACEUTICALS INC | 7M | $127.9M | 5.5% | — | — | 5 qtrssince 2019-Q1 | Increased 69 |
BRISTOL-MYERS SQUIBB CO | 1.7M | $94M | 4.0% | $37.46 | +57.84% | 5 qtrssince 2019-Q1 | Increased 56 |
STOKE THERAPEUTICS INC | 3.5M | $81.2M | 3.5% | $29.08 | -23.05% | 4 qtrssince 2019-Q2 | Unchanged 0 |
MIRATI THERAPEUTICS INC | 985,166 | $75.7M | 3.3% | — | — | 5 qtrssince 2019-Q1 | Increased 76 |
| 4.4M | $68.4M | 2.9% | — | — | 5 qtrssince 2019-Q1 | Increased 51 | |
ZIMMER BIOMET HOLDINGS INC | 671,457 | $67.9M | 2.9% | $113.12 | -21.20% | 3 qtrssince 2019-Q3 | Increased 71 |
MASIMO CORP | 382,915 | $67.8M | 2.9% | $139.18 | +29.15% | 5 qtrssince 2019-Q1 | Increased 51 |
IMMUNOVANT INC | 4.4M | $65.9M | 2.8% | $15.81 | +4.68% | 2 qtrssince 2019-Q4 | Unchanged 0 |
ADVERUM BIOTECHNOLOGIES INC | 6.6M | $64.8M | 2.8% | $56.11 | +95.87% | 5 qtrssince 2019-Q1 | Increased 53 |
AXSOME THERAPEUTICS INC | 1.1M | $61.9M | 2.7% | $33.42 | +72.31% | 5 qtrssince 2019-Q1 | Increased 52 |
BELLUS HEALTH INC NEW | 5.5M | $54.7M | 2.4% | — | — | 3 qtrssince 2019-Q3 | Increased 57 |
SAREPTA THERAPEUTICS INC | 529,261 | $51.8M | 2.2% | $123.90 | -20.48% | 5 qtrssince 2019-Q1 | Decreased 0 |
AXONICS INC | 1.7M | $43.4M | 1.9% | — | — | 5 qtrssince 2019-Q1 | Increased 49 |
VERICEL CORP | 4.5M | $40.9M | 1.8% | $14.78 | -37.47% | 5 qtrssince 2019-Q1 | Increased 63 |
NATERA INC | 1.3M | $37.8M | 1.6% | $30.88 | -3.29% | 3 qtrssince 2019-Q3 | Increased 74 |
FREQUENCY THERAPEUTICS INC | 2.1M | $36.9M | 1.6% | — | — | 2 qtrssince 2019-Q4 | Increased 65 |
TRANSLATE BIO INC | 3.7M | $36.8M | 1.6% | — | — | 5 qtrssince 2019-Q1 | Increased 51 |
RTW INVESTMENTS, LP manages $2.3B across 65 positions as of Q1 2020. Top holdings: RCKT (10.1%), ALNY (7.9%), PTCT (7.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.
Active quarter - 7 new positions, 3 exits, 38 increased. Top move: MRTX (INCREASED, conviction 76). Portfolio: $2.3B across 65 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR